Why a plan to lower prescription drug prices should not be piecemeal

Demand for prescription medications in the U.S. is at an all time high, given that 50% of adults have at least one chronic condition, and 25% have two or more. Sixty percent of the population, and 90% of Medicare beneficiaries have taken at least one prescription medication in the past month. Rising health care costs over time are leading to […]

Read more

Physicians more likely to prescribe opioids later in the day

It’s only human that decision-making changes when people are rushed. Researchers at the University of Minnesota and Harvard University conducted the first study in the United States to examine this phenomenon—using a national source of electronic health records—in primary care physicians when they decide whether to prescribe opioid painkillers. The findings were recently published in JAMA Network Open. Researchers looked […]

Read more

Netarsudil lowers IOP in glaucoma, ocular hypertension

(HealthDay)—Netarsudil ophthalmic solution (0.02 percent; once daily) significantly reduced mean intraocular pressure (IOP) among patients with open-angle glaucoma or ocular hypertension, according to a study published in the August issue of the American Journal of Ophthalmology. In a double-masked, randomized, phase 3, noninferiority study, Albert S. Khouri, M.D., from the Rutgers New Jersey School of Medicine in Newark, and colleagues […]

Read more

These common antibiotics could increase colon cancer risk

Although antibiotics can help kill harmful bacteria, the drugs may increase your risk for cancer, according to a new report. Researchers from Johns Hopkins University School of Medicine recently conducted a study, published in the journal Gut, to determine the association between oral antibiotic use and colon cancers. To do so, they examined the health records of nearly 30,000 people […]

Read more

Pediatric hematologists introduce a novel way to treat pediatric hemophilia A patients

An innovative way to treat pediatric hemophilia A patients using a combination approach has seen early success at the Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta, with researchers from Emory University School of Medicine. Now known as the Atlanta Protocol, in a nod to where the approach was developed, the new method involves treating patients with […]

Read more

Q&A: Deadly opioid crisis sparks lawsuits across the US

The first judgment is expected Monday in a lawsuit from a state government seeking to hold a drug company accountable for a U.S. opioid crisis that has ripped apart lives and communities. More trials and legal settlements are likely to follow the ruling in Oklahoma as the nation looks for answers and solutions to a massive societal and legal problem. […]

Read more

Opioid use and misuse three months after ED visit for acute pain

Opioid use at the three-month follow-up in emergency department patients discharged with an opioid prescription for acute pain is relatively low and not necessarily synonymous with opioid misuse. That is the conclusion of a study to be published in the August 2019 issue of Academic Emergency Medicine (AEM), a journal of the Society for Academic Emergency Medicine (SAEM). The lead […]

Read more

Ketamine isn’t an opioid and treats depression in a unique way

Ketamine has gotten a bad rap as an opioid when there’s plenty of evidence suggesting it isn’t one, Johns Hopkins experts say. They believe this reputation may hamper patients from getting necessary treatment for the kinds of depression that don’t respond to typical antidepressants. In a new paper, the researchers clarify the mechanism behind ketamine’s mechanism of action in hopes […]

Read more

Audit: Hospitals put Native Americans at risk with opioids

Government hospitals placed Native American patients at increased risk for opioid abuse and overdoses, failing to follow their own protocols for prescribing and dispensing the drugs, according to a federal audit released Monday. The report by the U.S. Department of Health and Human Services’ Office of Inspector General doesn’t draw any conclusions about actual abuse or overdoses. But it said […]

Read more

Data shows flood of opioids across US, many of them generics

The maker of OxyContin has been cast as the chief villain in the nation’s opioid crisis. But newly released government figures suggest Purdue Pharma had plenty of help in flooding the U.S. with billions of pills even as overdose deaths were accelerating. Records kept by the federal Drug Enforcement Administration show that 76 billion oxycodone and hydrocodone pills—the vast majority […]

Read more
1 2 3 8